Two Sigma Advisers LP lifted its stake in shares of Global Medical REIT Inc. (NYSE:GMRE - Free Report) by 375.3% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 167,300 shares of the company's stock after acquiring an additional 132,100 shares during the period. Two Sigma Advisers LP owned 0.25% of Global Medical REIT worth $1,292,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also bought and sold shares of the company. SG Americas Securities LLC lifted its holdings in Global Medical REIT by 13.8% during the fourth quarter. SG Americas Securities LLC now owns 25,828 shares of the company's stock worth $199,000 after acquiring an additional 3,128 shares during the period. Janney Montgomery Scott LLC raised its stake in shares of Global Medical REIT by 11.3% during the 4th quarter. Janney Montgomery Scott LLC now owns 143,447 shares of the company's stock worth $1,107,000 after purchasing an additional 14,532 shares during the period. Hodges Capital Management Inc. boosted its holdings in shares of Global Medical REIT by 37.8% in the 4th quarter. Hodges Capital Management Inc. now owns 31,000 shares of the company's stock worth $239,000 after buying an additional 8,500 shares during the last quarter. First Dallas Securities Inc. grew its position in Global Medical REIT by 13.7% during the fourth quarter. First Dallas Securities Inc. now owns 52,000 shares of the company's stock valued at $401,000 after buying an additional 6,250 shares during the period. Finally, Entropy Technologies LP purchased a new stake in Global Medical REIT during the fourth quarter worth about $179,000. 57.52% of the stock is owned by institutional investors.
Global Medical REIT Stock Performance
Global Medical REIT stock traded down $0.02 during mid-day trading on Wednesday, hitting $6.30. The company had a trading volume of 558,243 shares, compared to its average volume of 467,813. The company has a current ratio of 0.28, a quick ratio of 0.28 and a debt-to-equity ratio of 1.26. The company has a market capitalization of $421.29 million, a price-to-earnings ratio of -314.84, a P/E/G ratio of 1.43 and a beta of 1.23. The company's fifty day moving average is $7.20 and its 200-day moving average is $7.91. Global Medical REIT Inc. has a 12-month low of $6.06 and a 12-month high of $10.46.
Global Medical REIT (NYSE:GMRE - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.22 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.22. The company had revenue of $34.60 million for the quarter, compared to analysts' expectations of $35.49 million. Global Medical REIT had a return on equity of 0.86% and a net margin of 3.23%. Equities research analysts predict that Global Medical REIT Inc. will post 0.81 EPS for the current year.
Global Medical REIT Cuts Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 9th. Investors of record on Friday, June 20th will be issued a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a yield of 9.52%. Global Medical REIT's dividend payout ratio (DPR) is presently 2,000.00%.
Analysts Set New Price Targets
A number of equities analysts have recently commented on GMRE shares. B. Riley initiated coverage on Global Medical REIT in a report on Thursday, April 3rd. They issued a "neutral" rating and a $9.00 price target for the company. Wall Street Zen lowered shares of Global Medical REIT from a "hold" rating to a "sell" rating in a report on Thursday, May 22nd. Finally, Robert W. Baird cut their target price on shares of Global Medical REIT from $10.00 to $9.00 and set a "neutral" rating on the stock in a research note on Thursday, May 8th. One analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, Global Medical REIT has an average rating of "Hold" and an average target price of $10.44.
View Our Latest Stock Analysis on Global Medical REIT
About Global Medical REIT
(
Free Report)
Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
Featured Articles
Before you consider Global Medical REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Medical REIT wasn't on the list.
While Global Medical REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
